Man Group PLC Deciphera Pharmaceuticals, Inc. Transaction History

Man Group PLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$13.58 - $17.36 $138,339 - $176,846	10,187 Added 51.07%	30,134 $474,000
Q4 2023 Feb 14, 2024	BUY	$10.11 - $16.54 $201,664 - $329,923	19,947 New	19,947 $321,000
Q1 2023 May 15, 2023	BUY	$14.26 - $22.1 $142,813 - $221,331	10,015 New	10,015 $154,000
Q4 2021 Feb 14, 2022	SELL	$7.7 - $37.13 $259,020 - $1.25 Million	-33,639 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$26.46 - $37.15 $268,701 - $377,258	-10,155 Reduced 23.19%	33,639 $1.14 Million
Q2 2021 Aug 16, 2021	SELL	$32.73 - $47.95 $1.48 Million - $2.16 Million	-45,072 Reduced 50.72%	43,794 $1.6 Million
Q1 2021 May 17, 2021	SELL	$40.39 - $56.73 $1.94 Million - $2.72 Million	-47,910 Reduced 35.03%	88,866 $3.99 Million
Q4 2020 Feb 16, 2021	SELL	$51.77 - $66.18 $831,477 - $1.06 Million	-16,061 Reduced 10.51%	136,776 $7.81 Million
Q3 2020 Nov 16, 2020	BUY	$43.8 - $58.16 $953,175 - $1.27 Million	21,762 Added 16.6%	152,837 $7.84 Million
Q2 2020 Aug 14, 2020	BUY	$37.05 - $65.03 $3.16 Million - $5.55 Million	85,289 Added 186.28%	131,075 $7.83 Million
Q1 2020 May 15, 2020	SELL	$33.63 - $69.4 $257,168 - $530,701	-7,647 Reduced 14.31%	45,786 $1.89 Million
Q4 2019 Feb 18, 2020	BUY	$31.7 - $69.93 $685,766 - $1.51 Million	21,633 Added 68.03%	53,433 $3.33 Million
Q3 2019 Nov 14, 2019	BUY	$19.95 - $38.85 $634,410 - $1.24 Million	31,800 New	31,800 $1.08 Million
Q3 2018 Nov 14, 2018	SELL	$33.57 - $42.1 $98,494 - $123,521	-2,934 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$20.06 - $44.95 $58,856 - $131,883	2,934 New	2,934 $115,000

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.